Worst Biopharma CEO of 2024? It’s no contest

Taking stock of the drug industry, from the lab to the medicine chest

December 18, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Hyacinth Empinado/STAT STAT+ | Worst Biopharma CEO of 2024? It's no contest STAT's Adam Feuerstein explains all the ways in which the company's CEO, Remi Barbier, had a very bad year. By Adam Feuerstein STAT+ | FDA deputy commissioner Namandjé Bumpus to leave agency Namandjé Bumpus oversaw the FDA's recent reorganization, including the creation of a more unified human foods center. By Lizzy Lawrence Opinion: Dr. Glaucomflecken uses humor to spotlight the darkness in medicine Will Flanary, aka Dr. Glaucomflecken, on using comedy to trick people into caring about the health care system. By Torie Bosch

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser